Jones Financial Companies’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Sell
143,775
-17,641
-11% -$635K ﹤0.01% 1177
2026
Q1
$5.58M Buy
161,416
+161,383
+489,039% +$6.57M ﹤0.01% 1039
2025
Q4
$1.34K Buy
33
+20
+154% +$870 ﹤0.01% 3944
2025
Q3
$598 Sell
13
-16
-55% -$830 ﹤0.01% 4004
2025
Q2
$1.52K Buy
29
+16
+123% +$878 ﹤0.01% 3549
2025
Q1
$767 Buy
13
+1
+8% +$64 ﹤0.01% 3453
2024
Q4
$821 Sell
12
-4
-25% -$279 ﹤0.01% 3165
2024
Q3
$1.2K Buy
+16
New +$1.13K ﹤0.01% 2778
2024
Q1
Sell
-24
Closed -$2.63K 1379
2023
Q4
$2.63K Buy
24
+15
+167% +$1.55K ﹤0.01% 872
2023
Q3
$908 Buy
+9
New +$1.03K ﹤0.01% 641

Other funds holding CNMD

Jones Financial Companies's CNMD Position: Q2 2026 in Review

Jones Financial Companies reduced its CONMED (CNMD) stake by 11% in Q2 2026, selling an estimated $635K and leaving 143,775 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Jones Financial Companies first reported a position in CNMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $5.58M in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Jones Financial Companies held 143,775 shares of CONMED worth $5.17M as of Q2 2026.
  • Jones Financial Companies sold 17,641 CONMED shares in Q2 2026, an estimated $635K.
  • CONMED made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1177 holding.
  • Jones Financial Companies first reported a position in CONMED in Q3 2023 and has held it in 10 quarters since.
  • Jones Financial Companies's CONMED position peaked at $5.58M in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.